CNMD CONMED PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CNMD
- PE Ratio
As of Nov 5, 2025, the CONMED stock's P/E ratio is 12.48. This takes into account the latest EPS of $3.56 and stock price of $44.44. The PE ratio has decreased by 21% from its last 4 quarters average of 15.8.
CNMD PE ratio history
The PE ratio of CONMED has averaged 247.48 over the last ten years. The current price-to-earnings ratio of 12.48 is 95% less than the historical average. Analyzing the last ten years, CNMD's PE ratio reached its highest point in the Sep 2020 quarter at 3,933.5, when the price was $78.67 and the EPS was $0.02. The lowest point was recorded in the Jun 2025 quarter, when it reached 14.63 with a price of $52.08 and an EPS of $3.56.
CONMED PE ratio by year
Maximum annual increase: 3,332.29% in 2011
Maximum annual decrease: -97.72% in 2012
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 15.95 | -69.42% | $68.44 | $4.29 |
| 2023 | 52.15 | N/A | $109.51 | $2.1 |
| 2022 | N/A | N/A | $88.64 | -$2.68 |
| 2021 | 66.24 | -80.48% | $141.76 | $2.14 |
| 2020 | 339.39 | 206.53% | $112 | $0.33 |
| 2019 | 110.72 | 150.05% | $111.83 | $1.01 |
| 2018 | 44.28 | 72.9% | $64.2 | $1.45 |
| 2017 | 25.61 | -69.27% | $50.97 | $1.99 |
| 2016 | 83.34 | 108.09% | $44.17 | $0.53 |
| 2015 | 40.05 | 4.22% | $44.05 | $1.1 |
| 2014 | 38.43 | 17.56% | $44.96 | $1.17 |
| 2013 | 32.69 | 67.21% | $42.5 | $1.3 |
| 2012 | 19.55 | -97.72% | $27.95 | $1.43 |
| 2011 | 855.67 | 3,332.29% | $25.67 | $0.03 |
| 2010 | 24.93 | -54.08% | $26.43 | $1.06 |
CONMED PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 14.63 | -6.99% | $52.08 | $3.56 |
| Mar 2025 | 15.73 | -1.38% | $60.39 | $3.84 |
| Dec 2024 | 15.95 | -5.06% | $68.44 | $4.29 |
| Sep 2024 | 16.8 | -22.22% | $71.92 | $4.28 |
| Jun 2024 | 21.6 | -27.44% | $69.32 | $3.21 |
| Mar 2024 | 29.77 | -42.91% | $80.08 | $2.69 |
| Dec 2023 | 52.15 | 0.33% | $109.51 | $2.1 |
| Sep 2023 | 51.98 | 12.07% | $100.85 | $1.94 |
| Jun 2023 | 46.38 | N/A | $135.89 | $2.93 |
| Mar 2023 | N/A | N/A | $103.86 | -$3.17 |
| Dec 2022 | N/A | N/A | $88.64 | -$2.68 |
| Sep 2022 | N/A | N/A | $80.17 | -$2.8 |
| Jun 2022 | N/A | N/A | $95.76 | -$3.8 |
| Mar 2022 | 64.31 | -2.91% | $148.55 | $2.31 |
| Dec 2021 | 66.24 | 8.86% | $141.76 | $2.14 |
CNMD Price vs fair value
CNMD average PE ratio chart
CNMD's current PE ratio is under its 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 12.48, CNMD stands lower than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 25.01, CONMED's price to earnings (P/E) is 50% lower.
CNMD PE vs peers
CNMD's PE ratio is below its peer stocks JNJ and BSX. CONMED's current PE ratio of 12.48 is less than the average of its peers, which is 34.03.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 12.48 | $1.38B |
| JNJ Johnson & Johnson | 17.83 | $448.13B |
| MDT Medtronic plc | 24.84 | $115.95B |
| TFX Teleflex Inc | 28.81 | $5.51B |
| SYK Stryker Corp | 46.33 | $136.78B |
| BSX Boston Scientific Corp | 52.33 | $146.61B |
| IART Integra Lifesciences Holdings Corp | N/A | $887.97M |
Frequently asked questions
What is CONMED's PE ratio?
CNMD's price to earnings ratio is 12.48 as of Nov 5, 2025.
What is the 3-year average PE ratio for CONMED (CNMD)?
As an average over the last 3 years, CNMD stock has a PE ratio of 29.44.
What is the 5-year average PE ratio for CONMED (CNMD)?
As an average over the last 5 years, CNMD stock has a PE ratio of 76.85.
What is the highest PE ratio for CNMD?
Over the last ten years, the Sep 2020 quarter recorded the highest quarterly PE ratio at 3,933.5.
How does the current PE ratio for CNMD compare to its historical average?
CNMD's price to earnings ratio is currently 95% below its 10-year historical average.
How is CNMD's PE ratio calculated (CONMED PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 5, 2025), CONMED's share price is $44.44. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $3.56. Therefore, CONMED's price to earnings ratio for today is 12.48. PE RATIO(12.48) = STOCK PRICE($44.44) / TTM EPS($3.56)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.